CCELNYSEServices-Misc Health & Allied Services, NECFiscal year ends November 30
CRYO CELL INTERNATIONAL INC
Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 9, 2026
$4.65+0.23 (+5.20%)
Close on Oct 19, 2026
- Market cap
- $37.50M
- P/E (TTM)
- –
- Dividend yield
- –
Cryo Cell International statistics
Financials through Aug 31, 2026, price as of Oct 19, 2026, median of Services-Misc Health & Allied Services, NEC companies for comparison
Valuation
| Measure | Cryo Cell International | Industry median |
|---|---|---|
| Market Cap | $37.49M | $1.14B |
| Enterprise Value | $41.30M | $1.35B |
| PS Ratio | 1.20 | 1.63 |
| P/FCF Ratio | 8.06 | 20.54 |
| P/OCF Ratio | 7.62 | 15.44 |
Enterprise value
| Measure | Cryo Cell International | Industry median |
|---|---|---|
| EV / Sales | 1.33 | 1.78 |
| EV / EBITDA | 39.51 | 14.40 |
| EV / EBIT | 218.05 | 19.04 |
| EV / FCF | 8.88 | 23.16 |
Income (trailing twelve months)
| Measure | Cryo Cell International | Industry median |
|---|---|---|
| Revenue | $31.13M | $561.90M |
| Gross Profit | $24.45M | $173.32M |
| Operating Income | $189.42K | -$1.81M |
| Pretax Income | -$1.91M | -$572.42K |
| Net Income | -$1.95M | -$1.16M |
| EBITDA | $1.05M | -$20.72K |
| EPS (Diluted) | -$0.24 | -$0.02 |
Margins
| Measure | Cryo Cell International | Industry median |
|---|---|---|
| Gross Margin | 78.5% | 33.1% |
| Operating Margin | 0.61% | -4.45% |
| Pretax Margin | -6.13% | 1.54% |
| Profit Margin | -6.25% | -2.91% |
| EBITDA Margin | 3.36% | 2.41% |
| FCF Margin | 14.9% | 3.13% |
Returns
| Measure | Cryo Cell International | Industry median |
|---|---|---|
| Return on Assets (ROA) | -3.10% | -3.06% |
| Return on Capital Employed (ROCE) | 0.40% | -0.57% |
Growth
| Measure | Cryo Cell International | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -1.96% | 6.92% |
| FCF Growth (YoY) | -24.8% | -6.04% |
| Revenue Growth (3Y CAGR) | 1.33% | 10.9% |
| Revenue Growth (5Y CAGR) | 0.27% | 13.2% |
Balance sheet
| Measure | Cryo Cell International | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $4.23M | $48.71M |
| Total Debt | $8.04M | $140.00M |
| Net Cash (Debt) | -$3.81M | $205.49K |
| Net Cash Per Share | -$0.47 | $0.01 |
| Equity (Book Value) | -$16.39M | $235.16M |
| Book Value Per Share | -$2.03 | $3.48 |
| Tangible Book Value | -$19.17M | $703.69K |
| Working Capital | -$2.16M | $30.48M |
Financial position
| Measure | Cryo Cell International | Industry median |
|---|---|---|
| Current Ratio | 0.86 | 1.40 |
| Quick Ratio | 0.72 | 1.02 |
| Debt / EBITDA | 7.69 | 2.61 |
| Debt / FCF | 1.73 | 4.59 |
| Net Debt / EBITDA | 3.65 | 2.15 |
| Interest Coverage | 0.10 | -0.63 |
Cash flow (trailing twelve months)
| Measure | Cryo Cell International | Industry median |
|---|---|---|
| Operating Cash Flow | $4.92M | $3.10M |
| Capital Expenditures | -$268.87K | -$18.62M |
| Free Cash Flow | $4.65M | $23.73M |
| FCF Per Share | $0.58 | $0.37 |
Efficiency
| Measure | Cryo Cell International | Industry median |
|---|---|---|
| Asset Turnover | 0.50 | 0.87 |
| Inventory Turnover | 11.24 | 11.67 |
| Revenue Per Employee | $432.31K | $228.48K |
| Profits Per Employee | -$27.02K | -$8.65K |
| Employee Count | 72 | 913 |
Dividends and yields
| Measure | Cryo Cell International | Industry median |
|---|---|---|
| Earnings Yield | -5.19% | -1.25% |
| FCF Yield | 12.4% | 1.74% |
| FCF Payout Ratio | 0.00% | 12.0% |
Shares
| Measure | Cryo Cell International | Industry median |
|---|---|---|
| Shares Outstanding | 8,062,650 | 58,282,400 |
| Shares Change (YoY) | -1.39% | 2.68% |
| Shares Change (QoQ) | 0.00% | 0.32% |
| Float | 4,703,730 | 33,780,100 |
| Shares Held by Insiders | 41.7% | 16.4% |
| Shares Held by Institutions | 6.89% | 85.9% |
Taxes
| Measure | Cryo Cell International | Industry median |
|---|---|---|
| Income Tax | $36.82K | $697.00K |
Scores
| Measure | Cryo Cell International | Industry median |
|---|---|---|
| Altman Z-Score | -0.07 | 1.96 |
| Piotroski F-Score | 5 | 5 |
| Beneish M-Score | -3.18 | -2.71 |
Calculated by StockData from Cryo Cell International's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.